Lynn Seely
CIK 1327111 · President and CEO · last filed 2026-11-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDVN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 211
SAN FRANCISCO, CA 94107
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | President and CEO | 63,354 | $13.62 | $863.2K | -$340.4K | 16 | 2026-11-12 |
| ABCL | Director | — | $10.51 | — | $0 | 1 | 2026-07-06 |
| Blueprint Medicines Corp (BPMC) Delisted | Director | 0 | $129.46 | $0 | $0 | 13 | 2025-07-21 |
| Myovant Sciences Ltd. (MYOV) Delisted | Principal Executive Officer | 1,889,992 | $26.98 | $50.99M | $0 | 5 | 2020-04-07 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Medical Officer | 193,388 | — | — | -$37.38M | 40 | 2015-02-18 |
| MEDIVATION, INC. (MDV) Delisted | Chief Medical Officer | 9,000 | $18.05 | $162.4K | -$160.2K | 1 | 2007-03-20 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| MYOV | Direct | 1,043,824 | 55.2% | 2020-04-07 |
| By Seely Grantor Annuity Trusts | 846,168 | 44.8% | 2020-04-07 | |
| Total | 1,889,992 |
Recent Filings · Page 5 of 8
76 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-09-18 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$4.90M | EDGAR |
| 2014-09-11 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$1.68M | EDGAR |
| 2014-08-28 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$1.58M | EDGAR |
| 2014-08-14 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$1.50M | EDGAR |
| 2014-08-12 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$1.88M | EDGAR |
| 2014-07-23 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$504.2K | EDGAR |
| 2014-07-07 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$835.6K | EDGAR |
| 2014-02-20 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-06 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +7,000 | $0 | EDGAR |
| 2012-12-18 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).